Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness

  • Nat Genet. 2012 Jun 10;44(7):797-802. doi: 10.1038/ng.2325.
Saskia B Wortmann  1 Frédéric M Vaz Thatjana Gardeitchik Lisenka E L M Vissers G Herma Renkema Janneke H M Schuurs-Hoeijmakers Wim Kulik Martin Lammens Christin Christin Leo A J Kluijtmans Richard J Rodenburg Leo G J Nijtmans Anne Grünewald Christine Klein Joachim M Gerhold Tamas Kozicz Peter M van Hasselt Magdalena Harakalova Wigard Kloosterman Ivo Barić Ewa Pronicka Sema Kalkan Ucar Karin Naess Kapil K Singhal Zita Krumina Christian Gilissen Hans van Bokhoven Joris A Veltman Jan A M Smeitink Dirk J Lefeber Johannes N Spelbrink Ron A Wevers Eva Morava Arjan P M de Brouwer
Affiliations
  • 1. Department of Pediatrics, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands. [email protected]
Abstract

Using exome Sequencing, we identify SERAC1 mutations as the cause of MEGDEL syndrome, a recessive disorder of dystonia and deafness with Leigh-like syndrome, impaired Oxidative Phosphorylation and 3-methylglutaconic aciduria. We localized SERAC1 at the interface between the mitochondria and the endoplasmic reticulum in the mitochondria-associated membrane fraction that is essential for phospholipid exchange. A phospholipid analysis in patient fibroblasts showed elevated concentrations of phosphatidylglycerol-34:1 (where the species nomenclature denotes the number of carbon atoms in the two acyl chains:number of double bonds in the two acyl groups) and decreased concentrations of phosphatidylglycerol-36:1 species, resulting in an altered cardiolipin subspecies composition. We also detected low concentrations of bis(monoacyl-glycerol)-phosphate, leading to the accumulation of free Cholesterol, as shown by abnormal filipin staining. Complementation of patient fibroblasts with wild-type human SERAC1 by lentiviral Infection led to a decrease and partial normalization of the mean ratio of phosphatidylglycerol-34:1 to phosphatidylglycerol-36:1. Our data identify SERAC1 as a key player in the phosphatidylglycerol remodeling that is essential for both mitochondrial function and intracellular Cholesterol trafficking.